Huafeng Kang
机构:Second Affiliated Hospital of Xi'an Jiaotong University · ORCID:0000-0002-0379-530X
发表论文 166 篇 · 总被引 4114 次 · h-index 33
代表论文
- Bispecific Antibody Targeting VEGF/TGF‐β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects (2025 · Advanced Science · 被引 18)
- “On/off”-switchable crosslinked PTX-nanoformulation with improved precise delivery for NSCLC brain metastases and restrained adverse reaction over nab-PTX (2024 · Biomaterials · 被引 17)
- Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression (2024 · Cell Communication and Signaling · 被引 13)
- A Multistage‐Responsive Antibody‐Delivery Strategy to Improve Immunotherapy for NSCLC Brain Metastasis by Ultrasensitive Releasing and Tumor‐Anchoring (2024 · Advanced Functional Materials · 被引 13)
- Smoking cessation improves health status of patients with chronic diseases: evidence from a longitudinal study of older adults in China (2025 · BMC Public Health · 被引 7)
- PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer (2024 · Journal of Cancer Research and Clinical Oncology · 被引 6)